NEPH vs STE · P/E 48, rev $14.2M vs P/E 25, rev $5.46B
Nephros Inc (NEPH) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported NEPH revenue for 2024-12-31 was $14.2M. Net income was $74.0K. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
NEPH currently screens at market cap $40.9M and trailing P/E 48.3. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the NEPH and STE stock pages for the full models.
Not investment advice.